\newpage

\section{Tables}

\begin{table}[here]
\begin{center}
\begin{tabular}{l|c|c|c|c|c|c|c}
\hline
  & FACS & LCM & Manual & PAN & PAN.FACS & TRAP & Studies\\
\hline
Astrocyte & ✔ &  &  &  & ✔ &  & 2\\
\hline
Basket &  &  & ✔ &  &  & ✔ & 2\\
\hline
Bergmann &  &  &  &  &  & ✔ & 1\\
\hline
CerebGranule &  &  &  &  &  & ✔ & 1\\
\hline
Cholin &  &  &  &  &  & ✔ & 2\\
\hline
DentateGranule &  & ✔ &  &  &  &  & 1\\
\hline
Dopaminergic &  & ✔ &  &  &  &  & 2\\
\hline
Ependymal & ✔ &  &  &  &  &  & 1\\
\hline
GabaPV &  &  & ✔ &  &  &  & 3\\
\hline
GabaReln &  &  & ✔ &  &  &  & 1\\
\hline
GabaRelnCalb &  &  & ✔ &  &  &  & 1\\
\hline
GabaSSTReln &  &  & ✔ &  &  &  & 1\\
\hline
GabaVIPReln &  &  & ✔ &  &  &  & 1\\
\hline
Gluta &  &  & ✔ &  &  &  & 1\\
\hline
Golgi &  &  &  &  &  & ✔ & 1\\
\hline
Hypocretinergic &  &  &  &  &  & ✔ & 1\\
\hline
Microglia & ✔ &  &  &  &  &  & 1\\
\hline
MotorCholin &  &  &  &  &  & ✔ & 1\\
\hline
Oligo &  &  &  & ✔ &  & ✔ & 4\\
\hline
Purkinje &  & ✔ & ✔ &  &  & ✔ & 6\\
\hline
PyramidalCorticoThalam &  &  & ✔ &  &  &  & 1\\
\hline
Pyramidal\_Glt\_25d2 &  &  &  &  &  & ✔ & 1\\
\hline
Pyramidal\_S100a10 &  &  &  &  &  & ✔ & 1\\
\hline
Pyramidal\_Thy1 &  &  & ✔ &  &  &  & 1\\
\hline
Serotonergic &  &  &  &  &  & ✔ & 1\\
\hline
Spiny &  &  &  &  &  & ✔ & 4\\
\hline
Th\_positive\_LC &  &  & ✔ &  &  &  & 2\\
\hline
\end{tabular}

\caption{A summarization of the datasets collected. Check marks show the methods used to isolate cell types. Number of studies that contain the cell type are given on the right.}
\label{table:dataTable}
\end{center}
\end{table}


\section{Figures}

\begin{figure}[here]
\begin{center}
  \includegraphics[height = 8in]{figures/pipeline.png}
  \caption{Workflow of the project} % what will appear in index
  \label{fig:workflow}
\end{center}
\end{figure}

\begin{figure}[here]
\begin{center}
  \includegraphics[height = 8in]{figures/microarrayRnaSeq.png}
  \caption{A short summary of microarray (right) and RNA sequencing (left) methods.}
  \label{fig:microarrayRnaSeq}
\end{center}
\end{figure}



% \begin{figure}[here]
% \begin{center}
%   \includegraphics[height = 3in]{figures/RNAseq noise.png}
%   \caption{Taken from RNA sequencing shows low repeatability at low levels (Åabaj et al. 2011): Ranks of expression values for two indepent replicates are shown. Left figure left figure shows unmodified ranks. Right figure adds jitter to the points to reveal overplotting on the edges. The sample is taken from liver tissue}
%   \label{fig:labaj}
% \end{center}
% \end{figure}



\begin{figure}[here]
\begin{center}
  \includegraphics[height = 7in]{figures/isolationMethods.png}
  \caption{Example representations of cell type isolation techniques. A. Adapted from Kang et al. 2011. An example application of FACS. A fluorescently active molecule is used to label specific cell in the population. Upon detection of fluorescence, a charge is placed on the droplet whose path is later manipulated by an electrical field to separate the cells. B. Adapted from Cahoy et al. 2008. An example application of TRAP. A cell suspension is placed into a plate with bounded antibodies binding to a specific cell type. Removing suspended cells removes the cell type from the population. C. Adapted from Sanz et al. 2009. A schematic representation of the TRAP method. A cell type specific promoter driven expression of a labelled ribosome component causes certain cells to contain labelled ribosomes. The tissue is homogenized as a whole and fixed. Labelled ribosomes that carry RNAs from specific cells are isolated. Removal of ribosomes leaves cell type specific RNA samples behind. D. Adapted from Liotta et al. 2000. A schematic representation of LCM method. Cells are visually identified on the slide and marked. A laser then cuts the marked part and separates it from the rest of the samples.}
  \label{fig:isolationMethods}
\end{center}
\end{figure}

% \begin{figure}[here]
% \begin{center}
%   \includegraphics[height = 4in]{figures/pre-quantile.png}
%   \caption{Distribution of expression levels in between samples before quantile normalization. Different colors represent different studies included in the dataset}
%   \label{fig:pre-quantile}
% \end{center}
% \end{figure}

% \begin{figure}[here]
% \begin{center}
%   \includegraphics[height = 4in]{figures/after-quantile.png}
%   \caption{Distribution of expression levels in between samples after quantile normalization. Different colors represent different studies included in the dataset}
%   \label{fig:after-quantile}
% \end{center}
% \end{figure}

\begin{figure}[here]
\begin{center}
  \includegraphics[height = 3in]{figures/neuroexpresso.png}
  \caption{A screenshot of the NeuroExpresso web application: A tool to visualize gene expression in the cell types of our database.}
  \label{fig:neuroexpresso}
\end{center}
\end{figure}


\begin{figure}[here]
\begin{center}
  \includegraphics[height = 4in]{figures/cortexGenes.png}
  \caption{Expression of marker genes detected from cortex cell types. Values are scaled to be between 0 and 1, 0 representing the lowest observed expression level for the gene while 1 representing the highest. Samples and genes follow the same order of cell types to emphasize the specificity of the selected genes.}
  \label{fig:cortexGenes}
\end{center}
\end{figure}

\begin{figure}[here]
\begin{center}
  \includegraphics[height = 6in]{figures/allenValidate.png}
  \caption{Expression of known marker genes and newly discovered marker genes in Allen Brain Atlas (Lein et al. 2007) mouse brain in situ hybridization database. A. Expression of new and known markers of purkinje cells in cerebellum. B. Expression of new and known markers of granule cells in dentate gyrus, granule cell layer}
  \label{fig:allenValidate}
\end{center}
\end{figure}


\begin{figure}[here]
\begin{center}
  \includegraphics[height = 8in]{figures/hybridizationValidation.png}
  \caption{Triple labeling of fast spiking gabaergic cells in mouse cortex. NeuroTrace is a general neuronal marker. Slc32a1 and Pvalb are known markers of fast spiking pyramidal genes. Cox6a2 is a marker gene discovered through our analysis. Last row shows superimposition of known markers and Cox6a2 which appear in the same cells.}
  \label{fig:hybridizationValidation}
\end{center}
\end{figure}




\begin{figure}[here]
\begin{center}
  \includegraphics[height = 6in]{figures/singleCellCoexp.png}
  \caption{Binary heatmaps representing the expression of marker genes in single human and mouse cells. Significance stars represent the difference between coexistance of the genes and randomly selected gene sets with similar prevelance in the dataset. a-j shows the expression of marker genes in mouse single cells (Zeisel et al. 2015). k-t shows the expression of marker genes in single human cells (Darmanis et al. 2015). Since the data is collected specifically from frontal cortex, only cortex cell types are tested.}
  \label{fig:singleCellCoexp}
\end{center}
\end{figure}



\begin{figure}[here]
\begin{center}
  \includegraphics[height = 4in]{figures/whole-coexpression.png}
  \caption{In between coexpression levels of marker gene sets. Significance markers show significantly higher co-expression than co-expression between all genes}
  \label{fig:whole-coexpression}
\end{center}
\end{figure}


\begin{figure}[here]
\begin{center}
  \includegraphics[height = 6in]{figures/concordance.png}
  \caption{Pipeline for the upcoming analyisis on concordance of different cell type based analysis studies.}
  \label{fig:concordance}
\end{center}
\end{figure}

\begin{figure}[here]
\begin{center}
  \includegraphics[height = 6in]{figures/cortexWhite.png}
  \caption{Estimations of cortical cell types in frontal cortex and white matter. Values are normalized to be between 0 and 1. Estimations appropriately reflect expected differences between white and gray matter for the most part. It is also possible to see some unexpected increase of some pyramidal subtypes.}
  \label{fig:cortexWhite}
\end{center}
\end{figure}

\begin{figure}[here]
\begin{center}
  \includegraphics[height = 4in]{figures/purkinjeCereb.png}
  \caption{Estimations of purkinje cells in different brain regions. Values are normalized to be between 0 and 1. Purkinje cells are specific to the cerebellum.}
  \label{fig:purkinjeCereb}
\end{center}
\end{figure}

\begin{figure}[here]
\begin{center}
  \includegraphics[height = 4in]{figures/parkinsonMale.png}
  \caption{Estimations of dopaminergic cells in different substantia nigra of male parkinson's disease patients. Values are normalized to be between 0 and 1. Dopaminergic cell loss is an expected consequence of Parkinson's Disease}
  \label{fig:parkinsonMale}
\end{center}
\end{figure}

\begin{figure}[here]
\begin{center}
  \includegraphics[height = 6in]{figures/lm11MouseHumanSwap.png}
  \caption{A-B. Expression of the genes selected from a species in the samples used for isolation from the same species. A shows human genes in human cell type specific expression profile dataset while B is mouse genes in mouse cell type specific expression profile dataset. C-D. Expression of homologues of the genes selected from a species in cell type specific expression profile dataset of the other species. C shows human marker gene expressio in mouse samples while D shows mouse marker gene expression in human samples.}
  \label{fig:lm11MouseHumanSwap}
\end{center}
\end{figure}


\begin{figure}[here]
\begin{center}
  \includegraphics[height = 8in]{figures/lm11Estimations.png}
  \caption{Estimations done by our method (black) and Cibersory (red) are plotted against the real cell counts from the samples. Left axis shows our estimation values scaled between 0 and 1. Left axis shows Cibersort's estimate which is a percentage. A. Estimations done using marker genes selected from human cell type expression profiles. B. Estimations done using marker genes selected from mouse cell type expression profiles.}
  \label{fig:lm11Estimations}
\end{center}
\end{figure}


